Owens & Minor, Inc. (OMI)
NYSE: OMI · Real-Time Price · USD
8.58
+0.08 (0.94%)
At close: Mar 28, 2025, 4:00 PM
8.72
+0.14 (1.58%)
After-hours: Mar 28, 2025, 8:00 PM EDT
Owens & Minor Market Cap
Owens & Minor has a market cap or net worth of $662.78 million as of March 28, 2025. Its market cap has decreased by -65.49% in one year.
Market Cap
662.78M
Enterprise Value
2.84B
1-Year Change
-65.49%
Ranking
Category
Stock Price
$8.58
Market Cap Chart
Since December 1, 1998, Owens & Minor's market cap has increased from $545.50M to $662.78M, an increase of 21.50%. That is a compound annual growth rate of 0.74%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 28, 2025 | 662.80M | -34.23% |
| Dec 31, 2024 | 1.01B | -31.64% |
| Dec 29, 2023 | 1.47B | -0.99% |
| Dec 30, 2022 | 1.49B | -54.64% |
| Dec 31, 2021 | 3.28B | 65.06% |
| Dec 31, 2020 | 1.99B | 512.03% |
| Dec 31, 2019 | 324.90M | -17.58% |
| Dec 31, 2018 | 394.20M | -65.91% |
| Dec 29, 2017 | 1.16B | -46.73% |
| Dec 30, 2016 | 2.17B | -4.06% |
| Dec 31, 2015 | 2.26B | 2.16% |
| Dec 31, 2014 | 2.21B | -4.03% |
| Dec 31, 2013 | 2.31B | 27.67% |
| Dec 31, 2012 | 1.81B | 2.54% |
| Dec 30, 2011 | 1.76B | -5.43% |
| Dec 31, 2010 | 1.86B | 3.71% |
| Dec 31, 2009 | 1.80B | 15.37% |
| Dec 31, 2008 | 1.56B | -10.09% |
| Dec 31, 2007 | 1.73B | 37.84% |
| Dec 29, 2006 | 1.26B | 14.42% |
| Dec 30, 2005 | 1.10B | -1.08% |
| Dec 31, 2004 | 1.11B | 30.09% |
| Dec 31, 2003 | 853.70M | 52.42% |
| Dec 31, 2002 | 560.10M | -10.60% |
| Dec 31, 2001 | 626.50M | 6.66% |
View and export this data all the way back to 1998.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 738.61B |
| UnitedHealth Group | 472.03B |
| Johnson & Johnson | 394.52B |
| AbbVie | 363.15B |
| Novo Nordisk | 305.46B |
| AstraZeneca | 229.16B |
| Abbott Laboratories | 226.88B |
| Merck & Co. | 225.40B |